Muscle Fibre Type Dictates How Lungs’ Low Oxygen and Inflammation Reshape Mitochondria

Chronic obstructive pulmonary disease does not stop at the lungs. More than thirty percent of people living with COPD develop measurable skeletal muscle impairments, and those impairments track closely with exercise intolerance, declining quality of life and heavier reliance on healthcare services. For decades, clinicians have observed that limb muscles in these patients lose mitochondrial density, respiratory capacity and oxidative enzyme activity, while emitting more reactive oxygen species and opening their permeability transition pores more readily. What has remained stubbornly unclear is which of the disease’s many insults drives which part of this mitochondrial remodelling, and why some muscles deteriorate faster than others in the same patient.

A new study in the Journal of Cachexia, Sarcopenia and Muscle offers one of the cleanest answers yet. Working with young adult male Wistar rats, a French research team systematically separated two of the leading suspects in COPD-related muscle wasting, chronic alveolar hypoxia and chronic pulmonary inflammation, and then combined them. Their central finding is striking: the two stressors attack different muscles in different ways, and the pattern is dictated largely by fibre type. The oxidative, slow-twitch soleus and the glycolytic-leaning plantaris responded to the same four-week exposures with almost non-overlapping mitochondrial and metabolic signatures, and the combination of both stressors produced no simple additive damage.

The experimental design was deliberately surgical. Twenty-eight rats were divided into four groups for twenty-eight days: a normoxic control group, a group housed in chambers with ten percent inspired oxygen, a group receiving twice-weekly intratracheal instillations of lipopolysaccharide to provoke persistent lung inflammation, and a group receiving both. The final LPS dose was timed at least sixty hours before tissue collection to avoid contaminating the results with acute-phase inflammatory responses. Researchers then isolated mitochondria from the soleus and plantaris and subjected them to a battery of high-resolution assays, including Clark-type electrode oxygraphy for oxygen consumption, Amplex Red fluorimetry for hydrogen peroxide emission, and Calcium Green-5N spectrofluorimetry to measure how much calcium mitochondria could buffer before the permeability transition pore sprang open.

The hypoxia results told a story of selective vulnerability. In the plantaris, a muscle dominated by fast, glycolytic fibres with larger diameters and sparser capillary networks, four weeks at ten percent oxygen cut ADP-stimulated, Complex I-supported respiration by forty-five percent and reduced the activity of 3-hydroxyacyl-CoA dehydrogenase, a key enzyme of fatty acid oxidation, by nearly a third. The plantaris itself lost weight, and its Type IIb fibres shrank in cross-sectional area. Notably, hydrogen peroxide emission did not rise in this muscle, which the authors interpret as a coordinated downregulation of oxidative metabolism, possibly mediated by HIF-1α-driven induction of NDUFA4L2, a hypoxia-responsive protein known to dampen oxidative phosphorylation and limit electron leak. In other words, the glycolytic muscle appears to throttle its mitochondria down to avoid redox catastrophe, and pays for that protection with atrophy.

The soleus, by contrast, emerged as remarkably resilient to low oxygen. Its mitochondrial respiration, respiratory control ratio, muscle mass and fibre composition all held steady. But resilience came at a price: basal hydrogen peroxide release rose by nearly fifty-five percent when the mitochondria were fuelled with glutamate and malate, and the ratio of peroxide emission to oxygen consumption climbed as well, indicating that a larger fraction of electrons was leaking out of the respiratory chain to form reactive species. The team suggests this may reflect impaired scavenging by catalase or glutathione peroxidase, possibly offset by increased manganese superoxide dismutase activity. Crucially, the elevated ROS did not translate into pore opening, respiratory collapse or shrinkage, suggesting the oxidative muscle absorbed the hypoxic insult without structural damage.

Pulmonary inflammation drew an entirely different map. Repeated LPS instillations left mitochondrial respiration untouched in both muscles, yet they profoundly remodelled calcium handling and metabolic enzyme profiles. In the soleus, inflammation reduced the mitochondrial calcium retention capacity from roughly 624 to 445 nanomoles of calcium per milligram of protein, signalling that the permeability transition pore had become sensitised and would open at lower calcium loads. When the researchers added cyclosporin A, which inhibits cyclophilin D, a regulatory component of the pore, the effect vanished entirely. This is the first demonstration that chronic pulmonary inflammation sensitises the permeability transition pore in skeletal muscle, and it echoes findings in the muscles of COPD patients themselves. The authors speculate that proinflammatory mediators disrupt sarcoplasmic reticulum calcium homeostasis, flooding mitochondria with calcium and triggering recurring, transient, low-conductance pore openings that may serve as a protective reset rather than a lethal event.

Inflammation also rewired the metabolic identities of both muscles in opposite directions. In the soleus, glycerol-3-phosphate dehydrogenase activity rose by about sixteen percent in Type IIa fibres, hinting at a shift toward glycolysis that could compromise the postural endurance this muscle is built for. In the plantaris, the same enzyme fell by thirty to forty percent in Type I and IIa fibres, while the ratio of succinate dehydrogenase to glycerol-3-phosphate dehydrogenase rose across all fibre types, implying that even the highly glycolytic Type IIx and IIb fibres were being pushed toward oxidative metabolism. That forced metabolic migration may be functionally costly: fast fibres possess underdeveloped capillary networks, low myoglobin content and modest antioxidant defences, so their newfound oxidative lean may exceed what their structure can support, potentially eroding peak power output.

Perhaps the most consequential finding is what did not happen. Despite these profound mitochondrial and enzymatic shifts, fibre type composition barely moved. Only the plantaris showed a change, a modest rise in the proportion of Type IIx fibres under inflammation, and even that shift’s direction remained ambiguous. This means the mitochondrial defects documented here arise largely within the existing fibre population rather than through wholesale myosin heavy chain transitions. For COPD research, that reframes the problem: intrinsic mitochondrial maladaptation, not fibre type switching, may be the primary engine of muscle dysfunction, which opens the door to interventions aimed directly at mitochondrial quality control, calcium regulation and redox balance.

Equally important is the failure of the two stressors to compound. Across every measured parameter, the statistical analysis revealed no significant interaction between hypoxia and inflammation, indicating that the two insults operate through distinct, and in places opposing, molecular programmes. Hypoxia dominated the plantaris respiratory and fatty acid oxidation phenotypes, while inflammation overrode hypoxia’s influence on soleus calcium retention. The authors frame this as a contest between HIF-1α signalling, the hypoxic arm, and TNF-α-driven inflammatory signalling, with each condition capable of masking or modifying the other. The practical implication is that a single anti-wasting therapy is unlikely to serve all COPD patients; hypoxic muscle defects and inflammatory muscle defects may require separate, phenotype-specific rehabilitation and pharmacological strategies.

The study carries caveats worth noting. Hypoxia reliably suppressed food intake, and although prior work suggests hypoxia drives atrophy independently of hypophagia, the design could not fully disentangle the two. All animals were young adult males, so ageing-related vulnerability and sex-specific mitochondrial bioenergetics remain untested, and spontaneous locomotor activity was not tracked. Still, by cleanly fingerprinting two major COPD stressors in two fibre-type-distinct muscles, the work delivers a conceptual advance with real clinical resonance: the muscle wasting that shadows chronic lung disease is not one disease process but several, each written in the metabolic language of the fibre it invades, and each demanding its own countermeasure.

Subject of Research: Fibre type-specific mitochondrial and metabolic responses of rat skeletal muscle to chronic hypoxia and pulmonary inflammation relevant to COPD

Article Title: Skeletal Muscle Fibre Type Determines Mitochondrial and Metabolic Responses to Hypoxia and Pulmonary Inflammation in Young Adult Rats

Article References: Gavrielatos, A., Cottet‐Rousselle, C., Brocker, N., Tellier, C., Achouri, A., Prola, A., Dubouchaud, H., & Chabert, C. (2026). Skeletal Muscle Fibre Type Determines Mitochondrial and Metabolic Responses to Hypoxia and Pulmonary Inflammation in Young Adult Rats. Journal of Cachexia, Sarcopenia and Muscle, 17(5), Article e70382. https://doi.org/10.1002/jcsm.70382

Image Credits: AI Generated

DOI: 10.1002/jcsm.70382

Keywords: skeletal muscle, mitochondria, hypoxia, pulmonary inflammation, COPD, fibre type, soleus, plantaris, reactive oxygen species, permeability transition pore, oxidative phosphorylation, muscle atrophy